Enzyme Inhibitor Drugs

Known as: Enzyme Inhibitor Drug, Enzyme Inhibitor Agent, Enzyme Inhibitor 
 

Topic mentions per year

Topic mentions per year

1963-2018
010203019632018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PURPOSE To determine the dose-limiting toxicities (DLTs) and maximum tolerated dose (MTD) of the investigational NEDD8-activating… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
OBJECTIVES The aims of this study were to assess the prognostic value of cardiac troponin I levels, measured with a new high… (More)
  • figure 1
  • figure 2
  • table 5
Is this relevant?
2008
2008
Although dual blockade of the renin-angiotensin-aldosterone system (RAAS) with the combination of an angiotensin-converting… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2005
2005
Background. Patients with heart failure and reduced left ventricular (LV) ejection fraction (EF) manifest progressive LV… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2005
2005
Although angiotensin II type 1 (AT1) receptor antagonists and angiotensin-converting enzyme (ACE) inhibitors are known to reduce… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2003
2003
The pathomechanisms that cause renal damage in diabetes have not been completely clarified. Treatment with angiotensin-converting… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Background—Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by physicians in doses lower than the large… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1999
1999
Background—ACE inhibitors may not adequately suppress deleterious levels of angiotensin II in patients with heart failure. An… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • table 2
Is this relevant?
1993
1993
We have developed a new tobacco mosaic virus (TMV) RNA vector and have used it initially to systemically produce an angiotensin-I… (More)
Is this relevant?
1980
1980
The potent converting enzyme inhibitor (CEI) SQ14,225, which is known to prevent the formation of angiotensin II (AII) has been… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?